HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide.

AbstractBACKGROUND:
Plasma levels of adrenomedullin, a potent vasodilator peptide, are increased in cirrhotic patients, whereas its role in vascular hyporeactivity in cirrhosis has not been clarified.
METHODS:
Adrenomedullin expression was evaluated by radioimmunoassay and reverse-transcription polymerase chain reaction. Vascular reactivity to phenylephrine, alpha-adrenoceptor agonist, was investigated in the aortic rings from control rats and CCl-induced cirrhotic rats with ascites in the presence of the neutralizing antibody against adrenomedullin, human adrenomedullin and/or N-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor.
RESULTS:
Plasma adrenomedullin levels were significantly higher in cirrhotic rats than in controls (16.3 +/- 2.9 versus 7.4 +/- 1.7 fmol/mL, P < 0.05) and correlated negatively with systemic arterial pressure (r = -0.62, P < 0.05). Gene expression of adrenomedullin in various organs (liver, kidney, lung) and vessels (portal vein, aorta) was enhanced in cirrhotic rats compared with controls. Neutralizing antibody against adrenomedullin ameliorated the blunted contractile response to phenylephrine in cirrhotic aorta (Rmax: 1.5 +/- 0.1 versus 1.0 +/- 0.1 g/mg tissue, P < 0.05), whereas contraction remained unchanged in control aorta (Rmax: 1.9 +/- 0.2 versus 1.9 +/- 0.2 g/mg tissue). Intravenous infusion of human adrenomedullin induced a reduction of mean arterial pressure together with an increase of serum nitrate levels, which was abolished by neutralizing antibody against adrenomedullin. Human adrenomedullin caused a blunted contractile response to phenylephrine in both control and cirrhotic aortas, which was not observed in the presence of N-nitro-L-arginine methyl ester.
CONCLUSIONS:
These findings indicate that the overproduction of adrenomedullin may contribute to vascular hyporeactivity in cirrhosis via a release of nitric oxide.
AuthorsH Kojima, S Sakurai, M Uemura, H Satoh, T Nakashima, N Minamino, K Kangawa, H Matsuo, H Fukui
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 39 Issue 7 Pg. 686-93 (Jul 2004) ISSN: 0036-5521 [Print] England
PMID15370692 (Publication Type: Journal Article)
Chemical References
  • Adrenergic alpha-Agonists
  • Peptides
  • RNA, Messenger
  • Adrenomedullin
  • Phenylephrine
  • Nitric Oxide
Topics
  • Adrenergic alpha-Agonists (pharmacology)
  • Adrenomedullin
  • Animals
  • Aorta, Thoracic (drug effects)
  • Ascites (metabolism)
  • Kidney (metabolism)
  • Liver (metabolism)
  • Liver Cirrhosis (metabolism)
  • Lung (metabolism)
  • Male
  • Nitric Oxide (blood)
  • Peptides (genetics, metabolism)
  • Phenylephrine (pharmacology)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: